Extracorporeal photopheresis in Sezary syndrome: No significant effect in the survival of 44 patients with a peripheral blood T-cell clone

Archives of Dermatology

Volumn 134, Issue 8, 1998, Pages 1001-1005

  Fraser Andrews, Elisabeth ^a   Seed, Paul ^b   Whittaker, Sean ^a   Russell Jones, Robin ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; ETRETIN; ETRETINATE; FLUDARABINE PHOSPHATE; HYDROXYUREA; IMMUNOMODULATING AGENT; METHOTREXATE; PENTOSTATIN; PREDNISOLONE; PSORALEN; RAZOXANE; RETINOID; TETRACOSACTIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; ERYTHRODERMA; FEMALE; GENOTYPE; HUMAN; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; PRURITUS; PUVA; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA; AGE; AGED; BLOOD; CELL CLONE; CELL COUNT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GENETICS; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN TUMOR; SURVIVAL RATE; T LYMPHOCYTE;

AGE FACTORS; AGED; CELL COUNT; CLONE CELLS; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SEZARY SYNDROME; SKIN NEOPLASMS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 0031595287     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sézary A, Bouvrain Y. Erthrodermie avec presence de cellules monstreuses dans le derme et le sang circulant. Bull Soc Fr Dermatol Syphiligr. 1038;45:254-260.
2. Haynes B, Hensley L, Jegasothy B. Phenotypic characterisation of skin infiltrating T-cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood. 1980;60:463-473.
3. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med. 1987;316:297-303.
4. Schmitt IM, Moor AC, Patrignelli R, et al. Increased surface expression of class IMHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation. Tissue Antigens. 1995;46:45-49.
5. Kin YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol. 1995;131:1003-1008.
6. Lutzner MA, Emerit I, Dupepaire R, Flandrin G, Grupper C, Prunieras M. Cytogenetic cytophotometric and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small cell variant. J Natl Cancer Inst. 1973;50:1142-1162.
7. Duncan SC, Winkelmann RK. Circulating Sézary cells in hospitalized dermatology patients. Br J Dermatol. 1978;99:171-178.
8. Trotter MJ, Whittaker SJ, Orchard G, Smith NP. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol. 1997;24:286-291.
9. Weiss LM, Wood GS, Hu E, Abel EA, Hoppe RT, Sklar J. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sézary syndrome. J Invest Dermatol. 1989;92:601-604.
10. Whittaker SJ, Smith NP, Russell-Jones R, Luzzatto L. Analysis of beta, gamma and delta TCR genes in mycosis fungoides and Sézary syndrome. Cancer. 1991; 68:358-366.
11. Heald P, Rook A, Perez M, et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol. 1992; 27:427-433.
12. Zic J, Arzubiaga C, Salhany KE, et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1992;27:729-736.
13. Armus S, Keyes B, Cahill C, et al. Photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1990;23:898-902.
14. Prinz B, Behrens W, Hölzle E, Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: the Düsseldorf and Munich experience. Arch Dermatol Res. 1995;287:621-626.
15. Zic JA, Stricklin GP, Greer JP, et al. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol. 1996;35:935-945.
16. Gottlieb SL, Wolfe JT, Fox PE, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol. 1996;35:946-957.
17. Bourguin A, Tung R, Galili N, Sklar J. Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc Natl Acad Sci USA 1990;87:8536-8540.
18. Lim HW, Edelson RL. Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9:1117-1126.